Tenet Healthcare (THC) Gains from Sales and Divestitures (2009 - 2017)

Tenet Healthcare has disclosed Gains from Sales and Divestitures across 9 years of filings, most recently posting $960836.0 for Q1 2017.

• Gains from Sales and Divestitures for Q1 2017 came in at $960836.0, down 21.44% year-over-year; the trailing twelve-month figure through Mar 2017 was $960836.0 (down 21.44% YoY), and the FY2016 annual result was $1.6 million, up 35.9% from the prior year.
• Gains from Sales and Divestitures came in at $960836.0 for Q1 2017 at Tenet Healthcare, down from $1.6 million in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $1.6 million in Q4 2016 to a low of $839353.0 in Q1 2014.
• The 5-year median for Gains from Sales and Divestitures is $996363.0 (2015), against an average of $1.1 million.
• Across the five-year window, Gains from Sales and Divestitures slumped 76.04% in 2013 and jumped 41.41% in 2016, its largest moves.
• Tenet Healthcare's Gains from Sales and Divestitures stood at $966838.0 in 2013, then gained by 4.46% to $1.0 million in 2014, then grew by 19.83% to $1.2 million in 2015, then surged by 35.9% to $1.6 million in 2016, then tumbled by 41.58% to $960836.0 in 2017.
• The last three Gains from Sales and Divestitures figures came in at $960836.0 (Q1 2017), $1.6 million (Q4 2016), and $1.5 million (Q3 2016), per Business Quant data.